Share on LinkedInShare on LinkedIn

ARTICLE · 13 DECEMBER 2005

Insurance Market Update – December 2005 - Regulation

The implementation of the FSA’s Individual Capital Adequacy Standards regime in the UK has far-reaching consequences for all stakeholders in the insurance industry. The Use Test in particular, which seeks to embed a firm’s capital adequacy calculations in its risk management framework, will bring prudential capital into the boardroom as a tool for shaping strategy. Deloitte’s Roger Jackson explores the benefits of the new regime and suggests that firms that get on board early will be at a distin

United KingdomStrategy

Capital adequacy goes strategic

The implementation of the FSA’s Individual Capital Adequacy Standards regime in the UK has far-reaching consequences for all stakeholders in the insurance industry. The "Use Test" in particular, which seeks to embed a firm’s capital adequacy calculations in its risk management framework, will bring prudential capital into the boardroom as a tool for shaping strategy. Deloitte’s Roger Jackson explores the benefits of the new regime and suggests that firms that get on board early will be at a distinct advantage.

The Individual Capital Adequacy Standards (ICAS) regime in the UK has now been in place for nearly a year and the challenge has moved from discussing the proposals to calculating the number. This is set to change over the next couple of years, to how to embed a firm’s capital calculations into their risk management processes; what the FSA calls the "Use Test". As we shall see, this article explores some of the potential consequences on key

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from